Difference in the incidence of Clostridium difficile among patients infected with human immunodeficiency virus admitted to a public hospital and a private hospital.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMID 12452290)

Published in Infect Control Hosp Epidemiol on November 01, 2002

Authors

Joseph J Pulvirenti, Dale N Gerding, Catherine Nathan, Irfan Hafiz, Tarun Mehra, Dayle Marsh, Frank Kocka, Thomas Rice, Staci A Fischer, John Segreti, Robert A Weinstein

Articles by these authors

An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med (2005) 18.10

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol (2010) 17.99

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis (2006) 14.63

Targeted versus universal decolonization to prevent ICU infection. N Engl J Med (2013) 13.05

Burden of Clostridium difficile infection in the United States. N Engl J Med (2015) 8.17

Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol (2009) 7.89

Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med (2013) 7.75

Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med (2010) 7.37

Acinetobacter infection. N Engl J Med (2008) 6.47

Toxin B is essential for virulence of Clostridium difficile. Nature (2009) 5.49

Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm (2013) 5.02

Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis (2008) 4.92

Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis (2009) 4.87

Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep (2002) 4.64

T-helper-1-cell cytokines drive cancer into senescence. Nature (2013) 4.47

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA (2003) 4.09

Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol (2009) 3.66

A mouse model of Clostridium difficile-associated disease. Gastroenterology (2008) 3.65

Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol (2007) 3.60

Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis (2008) 3.32

Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology (2009) 3.29

Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis (2007) 3.15

Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 3.13

The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol (2015) 2.95

Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system. J Infect (2007) 2.84

Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med (2013) 2.78

Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med (2006) 2.71

Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals. J Clin Microbiol (2006) 2.52

Detecting unsuspected HIV infection with a rapid whole-blood HIV test in an urban emergency department. J Acquir Immune Defic Syndr (2007) 2.48

In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004. Antimicrob Agents Chemother (2007) 2.43

A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.32

Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol (2010) 2.32

Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.30

Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol (2010) 2.29

Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol (2002) 2.24

Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA (2010) 2.23

Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 2.22

Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis (2006) 2.14

Why don't they listen? Adherence to recommendations of infectious disease consultations. Clin Infect Dis (2004) 2.13

The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis (2013) 2.12

Residents' perspectives on ACGME regulation of supervision and duty hours--a national survey. N Engl J Med (2010) 2.11

Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission? Arch Intern Med (2007) 2.07

Development of a clinical data warehouse for hospital infection control. J Am Med Inform Assoc (2003) 2.02

Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis (2011) 2.01

Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis (2006) 1.99

Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis (2008) 1.98

Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin Infect Dis (2004) 1.98

Q fever: a biological weapon in your backyard. Lancet Infect Dis (2003) 1.97

A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis (2004) 1.96

Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis (2012) 1.96

Residents' response to duty-hour regulations--a follow-up national survey. N Engl J Med (2012) 1.94

Community-associated methicillin-resistant Staphylococcus aureus colonization burden in HIV-infected patients. Clin Infect Dis (2013) 1.92

Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases. Clin Infect Dis (2006) 1.89

Consumer-driven health plans: are they more than talk now? Health Aff (Millwood) (2003) 1.86

Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI). Vaccine (2009) 1.85

Strategies to prevent clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.84

Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile. Antimicrob Agents Chemother (2008) 1.84

Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.81

Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol (2010) 1.81

Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med (2007) 1.77

High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study. Pharmacotherapy (2011) 1.75

Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients' environment. Infect Control Hosp Epidemiol (2008) 1.74

Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper . Infect Control Hosp Epidemiol (2008) 1.73

Colonization for the prevention of Clostridium difficile disease in hamsters. J Infect Dis (2002) 1.68

Preventing transmission of multidrug-resistant bacteria in health care settings: a tale of 2 guidelines. Clin Infect Dis (2006) 1.66

Electronic interpretation of chest radiograph reports to detect central venous catheters. Infect Control Hosp Epidemiol (2003) 1.66

Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol (2008) 1.66

A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis. J Antimicrob Chemother (2013) 1.65

Comparison of strain typing results for Clostridium difficile isolates from North America. J Clin Microbiol (2011) 1.65

Prevention of bloodstream infections by use of daily chlorhexidine baths for patients at a long-term acute care hospital. Infect Control Hosp Epidemiol (2009) 1.64

The preventability of ventilator-associated events. The CDC Prevention Epicenters Wake Up and Breathe Collaborative. Am J Respir Crit Care Med (2015) 1.64

Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) (2013) 1.60

Approval and perceived impact of duty hour regulations: survey of pediatric program directors. Pediatrics (2013) 1.59

Transfer of vancomycin-resistant enterococci via health care worker hands. Arch Intern Med (2005) 1.58

Staphylococcus aureus and Clostridium difficile cause distinct pseudomembranous intestinal diseases. Clin Infect Dis (2004) 1.58

American Academy of Orthopaedic Surgeons clinical practice guideline on: the diagnosis of periprosthetic joint infections of the hip and knee. J Bone Joint Surg Am (2011) 1.57

Outcomes of offering rapid point-of-care HIV testing in a sexually transmitted disease clinic. J Acquir Immune Defic Syndr (2005) 1.56

Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J Med Microbiol (2004) 1.52

Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods. Med Care (2010) 1.51

Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol (2010) 1.51

Diagnosis of periprosthetic joint infections of the hip and knee. J Am Acad Orthop Surg (2010) 1.50

Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak. Infect Control Hosp Epidemiol (2010) 1.49

Numeracy and Medicare Part D: the importance of choice and literacy for numbers in optimizing decision making for Medicare's prescription drug program. Psychol Aging (2011) 1.48

Computer algorithms to detect bloodstream infections. Emerg Infect Dis (2004) 1.48

Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007. Anaerobe (2009) 1.47

Comparison of point-of-care rapid HIV testing in three clinical venues. AIDS (2004) 1.45

Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S. Pediatrics (2002) 1.44

Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins. J Clin Microbiol (2003) 1.43

Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Clin Infect Dis (2012) 1.42

Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis (2010) 1.41

Can limiting choice increase social welfare? The elderly and health insurance. Milbank Q (2006) 1.40

Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol (2009) 1.40